Theragnostics for tumor and plaque angiogenesis with perfluorocarbon nanoemulsions - Wikidata - wikimedia - TriplyDB

Theragnostics for tumor and plaque angiogenesis with perfluorocarbon nanoemulsions

Theragnostics for tumor and plaque angiogenesis with perfluorocarbon nanoemulsions

http://www.wikidata.org/entity/Q30474759

about

Therapeutic potential of ultrasound microbubbles in gastrointestinal oncology: recent advances and future prospects.Contact-facilitated drug delivery with Sn2 lipase labile prodrugs optimize targeted lipid nanoparticle drug delivery Cancer nanotheranostics: improving imaging and therapy by targeted delivery across biological barriers.Improving the performance of phase-change perfluorocarbon droplets for medical ultrasonography: current progress, challenges, and prospects.Vascular targeting of nanocarriers: perplexing aspects of the seemingly straightforward paradigm Phase-change contrast agents for imaging and therapy.Recent Advances in (19)Fluorine Magnetic Resonance Imaging with Perfluorocarbon Emulsions.Application of acoustic droplet vaporization in ultrasound therapy.Assessing the barriers to image-guided drug delivery.Perfluorocarbon nanoparticles for physiological and molecular imaging and therapy Perfluorocarbon nanoparticles: evolution of a multimodality and multifunctional imaging agent.Current status and prospects for microbubbles in ultrasound theranostics.Toward ultrasound molecular imaging with phase-change contrast agents: an in vitro proof of principle Phase-shift, stimuli-responsive perfluorocarbon nanodroplets for drug delivery to cancer.Phase-change nanoparticles using highly volatile perfluorocarbons: toward a platform for extravascular ultrasound imaging Ultrasound-mediated tumor imaging and nanotherapy using drug loaded, block copolymer stabilized perfluorocarbon nanoemulsions Improved signal processing to detect cancer by ultrasonic molecular imaging of targeted nanoparticles.Multifunctional agents for concurrent imaging and therapy in cardiovascular disease (19)F Magnetic Resonance Imaging Signals from Peptide Amphiphile Nanostructures Are Strongly Affected by Their Shape Perfluorocarbon nanoemulsions with fluorescent, colloidal and magnetic properties Macrophage targeted theranostics as personalized nanomedicine strategies for inflammatory diseases.Synergy between surface and core entrapped metals in a mixed manganese-gadolinium nanocolloid affords safer MR imaging of sparse biomarkers.Nanomedical Theranostics in Cardiovascular Disease.Polymer-based therapeutics: nanoassemblies and nanoparticles for management of atherosclerosis Assessment of the evolution of cancer treatment therapies Gd-based macromolecules and nanoparticles as magnetic resonance contrast agents for molecular imaging.Application of a hemolysis assay for analysis of complement activation by perfluorocarbon nanoparticles.Anti-angiogenesis therapy in the Vx2 rabbit cancer model with a lipase-cleavable Sn 2 taxane phospholipid prodrug using α(v)β₃-targeted theranostic nanoparticles.Emerging role of radiolabeled nanoparticles as an effective diagnostic technique.Nanotechnological strategies for therapeutic targeting of tumor vasculature.Antibody-based tumor vascular theranostics targeting endosialin/TEM1 in a new mouse tumor vascular model.Phosphatidylserine-Targeted Nanotheranostics for Brain Tumor Imaging and Therapeutic Potential.The effects of oil-in-water nanoemulsion polyethylene glycol surface density on intracellular stability, pharmacokinetics, and biodistribution in tumor bearing mice.19F molecular MR imaging for detection of brain tumor angiogenesis: in vivo validation using targeted PFOB nanoparticles.Using fluorochemical as oxygen carrier to enhance the growth of marine microalga Nannochloropsis oculata.The evolution of MRI probes: from the initial development to state-of-the-art applications

P2860

Q26777688-DF87F0A8-6218-4D52-ABB9-AA1B1495C7D4 Q26795703-2AB70E5F-77CF-4669-AA5B-E75A78CB3AEA Q26830028-B9503373-28B7-4FF5-A999-2FF800CBCB75 Q26861530-B170F29C-D789-4367-A22D-0D8E79C7BC31 Q27026630-84C29C1E-242E-4EB4-A0E2-2505CAD1A3CD Q30373053-74EF7C56-FE6F-42A3-B833-B8EE1CD6448E Q30385272-E68F6A34-0CAD-4B40-9BFD-6C91800CF131 Q30398863-3B0D9BE4-B9DA-4B4A-950E-4153C2F585B6 Q30422169-E05EA330-AC67-4FD9-8652-A9129F0B503A Q30426880-DCB2B5C4-C699-495C-9B19-1355C0932E11 Q30434964-C4C21B6F-2820-4FD5-9072-F2C42D8FA99A Q30435874-F9324A71-15BE-4974-83E1-2D4EE5A8763B Q30439339-2934E798-EB6D-4CEA-8026-B6E750E5EC3D Q30450131-76B7B9B2-73E6-4AE5-9BBD-B53EC7BE31FF Q30458493-A2305FFC-6BEC-42A5-A82B-230C0241EB8C Q30465710-85861D7D-39BD-4135-99C9-84507E92AC6E Q30467061-9BA3C217-73BE-4D4A-8AB9-20188E78E871 Q30474418-A15E4D5F-21C6-4216-B6C0-F05DE0FDE097 Q31115271-B29B58EC-A8DE-412F-8528-726657E21721 Q33760320-B658B67E-30F4-4B6C-88DE-4B907459DA33 Q34785236-BA086BA4-A3BD-44AE-9407-7DDCBA7B1282 Q35317271-55F7720D-AC66-4DC1-A5F7-741EEDFBC189 Q35681183-87D9F4BE-677C-4ED1-AFBB-981F2AF370AE Q35710262-CA1C79C4-915F-4D3F-8674-3E9857417CFE Q37137408-0F21BC3E-BF37-487F-9170-55AD6C3CE2FB Q37142843-D923789E-D1B8-4FB7-B429-3681D1CE2E02 Q37666126-C9104E57-422A-41AF-8FA7-C6BC176A5714 Q37695396-C3C22143-B8A7-45FF-B1FF-FE5DD10180BA Q38027231-52F27127-64EF-452D-B0DB-72A9F3BB3E3D Q38120320-D1558E8B-CCF3-4427-A098-415FAC0183C6 Q38662532-1B8DE0E6-3B17-4E84-BADC-E9648E5AC9F5 Q38707035-D04F8D67-050D-4622-AB84-D4452AD0ADF2 Q38944782-C6F42B93-7443-480F-813C-5C1FF1776AD6 Q39262306-E5FE2ABE-A0E8-4CAC-82ED-F4C3149F3D26 Q46805024-1D03BD68-188E-4E9F-A524-5C9A16B11C8D Q57768069-39AD6392-EB7A-462B-B880-3C655DBF22CB

P2860

Theragnostics for tumor and plaque angiogenesis with perfluorocarbon nanoemulsions

http://www.wikidata.org/entity/Q30474759

description

2010 nî lūn-bûn

@nan

2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Theragnostics for tumor and plaque angiogenesis with perfluorocarbon nanoemulsions

@ast

Theragnostics for tumor and plaque angiogenesis with perfluorocarbon nanoemulsions

@en

type

label

Theragnostics for tumor and plaque angiogenesis with perfluorocarbon nanoemulsions

@ast

Theragnostics for tumor and plaque angiogenesis with perfluorocarbon nanoemulsions

@en

prefLabel

Theragnostics for tumor and plaque angiogenesis with perfluorocarbon nanoemulsions

@ast

Theragnostics for tumor and plaque angiogenesis with perfluorocarbon nanoemulsions

@en

P1433

Q30474759-091FEA00-1D8D-4B97-8896-07D0737525DF

P1476

Q30474759-9704EB6B-DC87-4F60-92B4-A793C42E46A3

P2093

Q30474759-0BF5AAC6-8804-4AB6-8A3F-3495FA474EC3

Q30474759-238FF4CC-23BC-487F-B3AB-F115AE36DE9F

Q30474759-4C487ABF-C0CD-476B-B60D-DFEE80291EFA

Q30474759-70A7AFF9-64E9-4A57-A7D6-904123FC4C32

Q30474759-E3AA1E9B-B110-4E9B-9DE7-1881847B2EDE

Q30474759-E7DDEC25-DEE9-449C-8B0A-F33EFEA7F86D

P2860

Q30474759-004EB1D3-E5C6-44FD-B971-5D2299382747

Q30474759-057BF49F-BCE7-4A60-8535-E457BFD0BEAE

Q30474759-08145306-C6E2-400F-80B0-58FE96284E72

Q30474759-11620FC1-899D-4A90-A7EA-0D87BE3D8174

Q30474759-1210C8B8-1B7D-40A7-8CA8-084BCE72B17B

Q30474759-134A51C1-8E1A-4437-B29B-A564830E5520

Q30474759-1519EAEE-D976-45A2-B1B6-FDA7C2D46FB6

Q30474759-19A26762-167A-4DEF-BDB2-675ADD5632B1

Q30474759-19F3F186-670E-460C-AAA5-4F49244005AF

Q30474759-1A80A6E3-CA09-42D3-8606-94D312F2BDA9

P2888

Q30474759-7A3FE50C-F13D-4062-BA80-0F1A4329AB5F

P304

Q30474759-E09829B4-69FC-40BA-876F-DF980928ECD6

P31

Q30474759-1F5C6ED9-A5DF-4765-8E8E-4F07557042A1

P356

Q30474759-DB458997-E6F6-45EA-BEE1-CC34223BFD65

P433

Q30474759-A6962246-86AB-40E3-824C-2B156C0D537D

P478

Q30474759-06F60EC2-5AA6-4BBC-B1DC-91EE4229D366

P50

Q30474759-7AC92677-43AE-4582-876F-A8286A641C58

P577

Q30474759-F214265A-9175-49FC-9FA3-51807332EA6B

P5875

Q30474759-BB21B4DD-E96A-42C7-984A-94B77466560D

P698

Q30474759-94D2C229-BEEC-4056-9FF1-32ADCDC3B5D3

P932

Q30474759-B615E866-6987-4D23-AE46-78BB8FD372D1

P356

S10456-010-9166-0

P1433

P1476

Theragnostics for tumor and plaque angiogenesis with perfluorocarbon nanoemulsions

@en

P2093

A H Schmieder

http://www.w3.org/2001/XMLSchema#string

G M Lanza

http://www.w3.org/2001/XMLSchema#string

Grace Hu

http://www.w3.org/2001/XMLSchema#string

M S Hughes

http://www.w3.org/2001/XMLSchema#string

S A Wickline

http://www.w3.org/2001/XMLSchema#string

S D Caruthers

http://www.w3.org/2001/XMLSchema#string

P2860

The anti-angiogenic agent fumagillin covalently binds and inhibits the methionine aminopeptidase, MetAP-2

Structure of human methionine aminopeptidase-2 complexed with fumagillin

Tumor angiogenesis: therapeutic implications

The homeobox transcription factor Hox D3 promotes integrin alpha5beta1 expression and function during angiogenesis

AG-013736, a novel inhibitor of VEGF receptor tyrosine kinases, inhibits breast cancer growth and decreases vascular permeability as detected by dynamic contrast-enhanced magnetic resonance imaging

Application of Renyi entropy for ultrasonic molecular imaging.

Perfluorocarbon nanoemulsions for quantitative molecular imaging and targeted therapeutics.

Detection of targeted perfluorocarbon nanoparticle binding using 19F diffusion weighted MR spectroscopy

Improved molecular imaging contrast agent for detection of human thrombus.

Lipid-based nanoparticles for contrast-enhanced MRI and molecular imaging.

P2888

s10456-010-9166-0

P304

189-202

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10456-010-9166-0

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-04-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

43248446

http://www.w3.org/2001/XMLSchema#string

P698

20411320

http://www.w3.org/2001/XMLSchema#string

P932

3140871

http://www.w3.org/2001/XMLSchema#string